I now have comprehensive data from Campbell's Operative Orthopaedics, Bailey & Love's Surgery, and Tintinalli's Emergency Medicine. Let me compile the full answer.
Clostridium tetani - Tetanus in Orthopaedic Infection
Etiology
Clostridium tetani is a motile, non-encapsulated, anaerobic gram-positive spore-forming bacillus. It occurs naturally in the intestines of humans and animals and in soil. Key etiological points:
- Spores are ubiquitous in soil, animal feces, and environmental surfaces - they can survive for years
- Enters the body through wounds (puncture wounds, open fractures, lacerations, abrasions, burns, frostbite, bite injuries)
- In agricultural areas, spores can be found on skin or in contaminated heroin
- No wound is identified in up to 10% of tetanus cases - it can also occur after surgical procedures, otitis media, or abortion
- Once inside the body, spores germinate into the toxin-producing vegetative form when tissue oxygen tension is reduced (anaerobic conditions)
Tetanus-prone wounds (as defined by the American College of Surgeons) include:
- Wound >6 hours old
- Stellate, avulsion, or crush injury
- Abrasion, bite, or needle wound
- Depth >1 cm
- Missile injury
- Burn or frostbite
- Foreign body under the skin
- Infected, devitalized, denervated, or ischemic tissue
- Contaminants (dirt, feces, soil, saliva) present in the wound
(Campbell's Operative Orthopaedics 15th Ed, eBOX 58.1)
Pathology / Pathophysiology
C. tetani produces two exotoxins:
- Tetanolysin - facilitates growth of the bacterial population by lysing red blood cells and disrupting surrounding tissue
- Tetanospasmin - a powerful neurotoxin responsible for ALL clinical manifestations of tetanus
Mechanism of tetanospasmin:
- Reaches the nervous system via hematogenous spread to peripheral nerves, then retrograde intraneuronal transport to the CNS
- Does NOT cross the blood-brain barrier directly - retrograde intraneuronal transport gives it CNS access
- Binds to neuromuscular junctions of CNS neurons, rendering them incapable of neurotransmitter release
- Prevents release of inhibitory neurotransmitters glycine and GABA from presynaptic nerve terminals
- This releases the nervous system from its normal inhibitory control, leading to failure of inhibition of motor reflex responses to sensory stimulation
- Agonist and antagonist muscles contract simultaneously, producing tetanic spasms
- Loss of inhibition also affects preganglionic sympathetic neurons, producing sympathetic overactivity and high circulating catecholamines
(Tintinalli's Emergency Medicine; Bailey & Love's 28th Ed)
Signs and Symptoms
Incubation period: Median 7 days (range: <24 hours to >1 month). Shorter incubation = more severe disease and worse prognosis.
Three Clinical Forms
1. Generalized Tetanus (~80% of cases)
- Most common presenting complaints: pain and stiffness in the masseter muscles ("lockjaw"/trismus)
- Progression is descending: facial muscles first (short axons), then neck, trunk, and extremities
- Risus sardonicus (sardonic smile) - the classic fixed grimace from facial muscle spasm:
Figure: Risus sardonicus of 'lockjaw' (Bailey & Love's 28th Ed, Fig. 33.15)
- Opisthotonus - arching of the whole body from spasm of paravertebral and extensor limb muscles
- Reflex convulsive spasms and tonic contractions cause dysphagia, arm flexion, fist clenching, lower limb extension
- Laryngeal spasm leads to apnoea, asphyxia, and respiratory arrest
- Spasms triggered by the slightest sensory stimulus
- Spasms last 3-4 weeks; recovery may take months
- Mental status remains NORMAL (important differentiating feature) unless respiratory compromise occurs
- Autonomic dysfunction: tachycardia, labile hypertension, diaphoresis, arrhythmias
- Complications: rhabdomyolysis, long bone fractures from violent muscle contractions, aspiration pneumonia (present in 50-70% of autopsied cases)
2. Cephalic Tetanus
- Follows head injuries or otitis media
- Cranial nerve dysfunction, most commonly CN VII (facial nerve)
- Poor prognosis
3. Local Tetanus
- Muscle rigidity confined to the site of injury
- Usually resolves after weeks to months
- May progress to generalized form
- ~1% fatality rate
Investigation
Tetanus is a clinical diagnosis - no laboratory test confirms it.
Key investigative points:
- Serum antitoxin titers >0.01 IU/mL are usually protective, but tetanus can still occur even with protective levels
- An immunochromatographic dipstick test allows rapid assessment of immunity (88% sensitivity, 98% specificity) - useful in high-incidence regions
- Wound culture has limited value: C. tetani may be cultured from wounds without clinical disease, and may NOT be recovered in confirmed tetanus cases
- In the USA, 96% of cases occur in patients with unknown or inadequate immunization history
- The elderly, those on hemodialysis, and immunocompromised patients often have inadequate immunity
Differential Diagnosis:
| Condition | Distinguishing Feature |
|---|
| Strychnine poisoning | Most closely mimics generalized tetanus |
| Dystonic reaction (phenothiazines, metoclopramide) | Drug history |
| Hypocalcaemic tetany | Low calcium; no trismus |
| Malignant neuroleptic syndrome | Antipsychotic use, altered consciousness |
| Serotonin syndrome | Serotonergic drug use |
| Stiff person syndrome | Chronic, centrally mediated; proximal lower limbs |
| Rabies | Altered consciousness, hydrophobia |
| Meningitis / SAH | Neck stiffness, altered consciousness |
(Tintinalli's Emergency Medicine, Table 157-1)
Treatment
1. Prevention (most important)
Active immunization:
- 0.5 mL tetanus toxoid IM for wounds contaminated with soil or at risk
- Booster dose for patients previously immunized
- A full active immunization series must be started in unimmunized patients
Passive immunization:
- Human anti-tetanus globulin (ATG) / Human Tetanus Immunoglobulin (HTIG): 250-500 U IM for patients with tetanus-prone wounds or those not previously immunized
- Can be given simultaneously with toxoid - separate syringes and separate injection sites must be used
- ATG provides longer-lasting protection than equine antitoxin
- Wound debridement should be performed a few hours after ATG to minimize tetanospasmin release
Tetanus Prophylaxis Guide (Campbell's Operative Orthopaedics 15th Ed):
| Immunization History | Clean Minor Wound | All Other Wounds |
|---|
| Unknown or <3 doses | Toxoid + HTIG | Toxoid + HTIG |
| ≥3 doses, last booster <5 yrs | Toxoid only (if needed) | Nothing required |
| ≥3 doses, last booster 5-10 yrs | Nothing required | Toxoid only |
| ≥3 doses, last booster >10 yrs | Toxoid only | Toxoid only |
2. Local Wound Care
- Thorough wound debridement to eliminate the anaerobic environment, remove spores, and prevent further toxin production
- Remove all devitalized and ischemic tissue
- Wound closed using delayed primary or secondary closure techniques
- IV Penicillin G 10-24 million units/day for 10-14 days (metronidazole is an effective alternative)
3. Supportive Care for Established Disease
- ICU admission mandatory - free from strong sensory stimuli (minimize light, noise, touch)
- Immediate neuromuscular blockade and intubation for respiratory compromise
- Diazepam to prevent onset of spasms; if spasms become sustained, the patient is paralysed, intubated, and placed on a ventilator
- Gradual ventilator weaning under anticonvulsant cover
- Intrathecal antitoxin has been used for spasm control to avoid ventilatory support
- Provide tetanus immunization: the disease does NOT confer immunity
Human Tetanus Immunoglobulin (HTIG) in established disease:
- Neutralizes circulating toxin (cannot reverse toxin already bound to nerve terminals)
- 500 U IM is the recommended dose for active tetanus
Prognosis:
- Overall mortality ~45% in full-blown disease (Bailey & Love); 7% in developed countries with modern ICU care (CDC 2009-2017 data)
- Prognosis determined by incubation period and the interval from first symptom to first tetanic spasm - shorter intervals = worse prognosis
- Survivors may require several weeks of hospitalization
- Without access to mechanical ventilation, mortality remains very high
Sources:
- Campbell's Operative Orthopaedics 15th Ed 2026, eBOX 58.1 / eTable 58.1
- Bailey and Love's Short Practice of Surgery 28th Ed, Ch. 33
- Tintinalli's Emergency Medicine: A Comprehensive Study Guide, Ch. 157